{"id":"NCT00679432","sponsor":"Bausch Health Americas, Inc.","briefTitle":"(CB-01-02/01) Randomized Placebo Controlled Trial of Budesonide-multi-matrix System (MMX™) 6 mg and 9 mg in Patients With Ulcerative Colitis","officialTitle":"Efficacy and Safety of New Oral Budesonide-MMX™ (CB-01-02) 6 mg and 9 mg Extended Release Tablet Formulations in Patients With Mild or Moderate, Active Ulcerative Colitis. A Multicenter, Randomized, Double-blind, Double Dummy Comparative Study Versus Placebo, With an Additional Reference Arm Evaluating Asacol® 2400 mg.","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2008-06","primaryCompletion":"2010-05","completion":"2010-06","firstPosted":"2008-05-16","resultsPosted":"2014-08-01","lastUpdate":"2019-12-10"},"enrollment":510,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Ulcerative Colitis"],"interventions":[{"type":"PROCEDURE","name":"Blood sampling, endoscopy","otherNames":[]},{"type":"DRUG","name":"budesonide-MMX® 6 mg","otherNames":[]},{"type":"DRUG","name":"budesonide-MMX® 9 mg","otherNames":[]},{"type":"DRUG","name":"Placebo","otherNames":[]},{"type":"DRUG","name":"Asacol® 400 mg","otherNames":[]}],"arms":[{"label":"1: budesonide-MMX® 6 mg","type":"EXPERIMENTAL"},{"label":"2: budesonide-MMX® 9 mg","type":"EXPERIMENTAL"},{"label":"3: Placebo","type":"PLACEBO_COMPARATOR"},{"label":"4: Asacol® 400 mg","type":"ACTIVE_COMPARATOR"}],"summary":"The purpose of this study is to compare Budesonide MMX™ 6 mg and Budesonide MMX™ 9 mg tablets to placebo and to Asacol 6x 400 mg tablets over an 8-week treatment period to determine if Budesonide MMX™ is effective in the treatment of ulcerative colitis.","primaryOutcome":{"measure":"Clinical and Endoscopic Remission.","timeFrame":"8 weeks","effectByArm":[{"arm":"1: Budesonide-MMX® 6 mg","deltaMin":13.2,"sd":null},{"arm":"2: Budesonide-MMX® 9 mg","deltaMin":17.9,"sd":null},{"arm":"3: Placebo","deltaMin":7.4,"sd":null},{"arm":"4: Asacol® 400 mg","deltaMin":12.1,"sd":null}],"pValues":[{"comp":"OG000 vs OG002","p":"0.1393"},{"comp":"OG001 vs OG002","p":"0.0143"},{"comp":"OG002 vs OG003","p":"0.2200"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":1,"exclusionCount":1},"locations":{"siteCount":105,"countries":["United States","Canada","India","Mexico"]},"refs":{"pmids":["22892337"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":2,"n":126},"commonTop":["Colitis ulcerative","Headache","Nausea","Abdominal pain","Insomnia"]}}